- Conditions
- Retinopathy of Prematurity (ROP)
- Interventions
- FLQ-101
- Drug
- Lead sponsor
- FELIQS INC.
- Industry
- Eligibility
- 4 Days to 5 Days
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Austin, Texas
Source: ClinicalTrials.gov public record
Updated Apr 20, 2026 · Synced May 22, 2026, 1:08 AM EDT